<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMM</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Medicine</journal-title></journal-title-group>
<issn pub-type="ppub">1107-3756</issn>
<issn pub-type="epub">1791-244X</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ijmm.2016.2693</article-id>
<article-id pub-id-type="publisher-id">ijmm-38-04-1312</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject></subj-group></article-categories>
<title-group>
<article-title>Systemic delivery of synthetic microRNA-451 is an effective therapeutic strategy for the treatment of lung cancer</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Lou</surname><given-names>Baisong</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Zhou</surname><given-names>Xin</given-names></name></contrib></contrib-group>
<pub-date pub-type="ppub">
<month>10</month>
<year>2016</year></pub-date>
<pub-date pub-type="epub">
<day>29</day>
<month>07</month>
<year>2016</year></pub-date>
<volume>38</volume>
<issue>4</issue>
<fpage>1312</fpage>
<lpage>1312</lpage>
<permissions>
<copyright-statement>Copyright: &#x000A9; Lou et al.</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions></article-meta></front>
<body>
<p>Int J Mol Med 35: <related-article id="RA1" related-article-type="retracted-article" vol="35" page="1369">1369&#x02013;1373</related-article>, 2015; DOI: 110.3892/ijmm.2015.2147</p>
<p>Following the publication of this article, an interested reader drew to our attention that Figs. 3B and 4B contained histological data which had previously been published in Figs. 3B and 4B, respectively, of the following article: Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D and Bader AG: Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res. 15: 5923&#x02013;5930, 2010.</p>
<p>We have tried to contact the authors of the above paper on several occasions for comment, but without success; therefore, the Editorial Board of the <italic>International Journal of Molecular Medicine</italic> has taken the decision to retract this publication. We thank the reader for drawing this matter to our attention.</p></body></article>
